Spatial Drug Distribution Analysis Service

Spatial Insights for Optimizing Drug Efficacy and Safety

Our Spatial Drug Distribution Analysis service uses advanced Mass Spectrometry Imaging (MSI) to provide label-free, high-resolution maps of drugs and their metabolites directly within tissue sections. With this approach, you can see exactly where your compound distributes, how it penetrates heterogeneous tissues, and how it engages targets or accumulates off-target, giving you insights that traditional pharmacokinetic methods cannot provide. These spatially resolved data enable smarter decisions for optimizing drug efficacy, safety, and delivery strategies, making the service an invaluable tool for modern drug development, translational research, and precision medicine initiatives.

Submit Your Request Now

Submit Your Request Now

What is
Platform
Workflow
Advantages
Applications
Why choose
FAQs
Sample preparation
Case Study
Reference

What is Spatial Drug Distribution Analysis

Spatial Drug Distribution Analysis is an analytical approach that combines mass spectrometry–based imaging or elemental imaging technologies with histological context to map the in situ localization and concentration of pharmaceutical compounds in biological tissues. It allows drugs, metabolites, and delivery vehicles to be detected label-free, preserving native tissue architecture while providing molecular specificity.

By integrating spatial resolution with quantitative capabilities, this analysis bridges the gap between pharmacokinetics, pharmacodynamics, and tissue pathology. It answers key questions such as whether a drug reaches its intended target region, how evenly it penetrates diseased tissue, and whether local accumulation correlates with efficacy or toxicity.

Platform

Spatial drug distribution is primarily achieved through advanced imaging platforms, including:

Technology	What It Detects	Why Choose This Technology	Key Considerations
MALDI-MSI / DESI-MSI	Small-molecule drugs and their metabolites	Label-free imaging; drug & metabolite co-detection; tissue-level distribution	Moderate spatial resolution; quantification requires calibration
SIMS	Small molecules, metal-containing drugs	Ultra-high resolution; subcellular localization	Limited molecular coverage; not suitable for large molecules
LA-ICP-MS	Metal elements, metal-based drugs, nanodrugs	Absolute quantification; high sensitivity; metal-specific imaging	Elemental information only; not applicable to organic drugs

Workflow

spatial drug distribution analysis workflow

Advantages

True spatial resolution of drug exposure within tissues
Label-free detection, avoiding altered pharmacokinetics
Simultaneous analysis of parent drugs and metabolites
Quantitative or semi-quantitative capability at region-specific levels
Direct correlation with histopathology and therapeutic outcomes

Applications

Oncology drug development: evaluating tumor penetration, intratumoral heterogeneity, and resistance mechanisms
Nanomedicine and drug delivery systems: assessing targeting efficiency and biodistribution
CNS drug research: investigating blood–brain barrier penetration
Toxicology and safety studies: identifying local drug accumulation linked to adverse effects
Translational and preclinical research: linking local drug exposure to efficacy or failure

Why Choose Spatial Drug Distribution Analysis?

Comprehensive Spatial Imaging Platform
Access MALDI/DESI-MSI, SIMS, and LA-ICP-MS to support diverse drug modalities and research needs.
Label-Free, In Situ Drug Visualization
Directly map drugs and metabolites within intact tissues while preserving biological context.
Quantitative, Actionable Insights
From spatial profiling to absolute quantification, connect local drug exposure with efficacy and safety.
Expert-Led, Customized Support
Study design and workflows tailored to your scientific goals, backed by experienced analytical specialists.

FAQs

At what spatial scale is drug distribution typically analyzed?

Most studies are performed at the tissue (histological) level, where drug localization can be reliably correlated with pathology. Subcellular analysis is possible but is generally reserved for specialized mechanistic studies.

Can you provide quantitative results?

Yes. We offer relative, semi-quantitative, and absolute spatial quantification, depending on the technology and study design. Quantification strategies are defined during project consultation.

Can results be correlated with histology?

Yes. Spatial drug distribution data can be co-registered with H&E or IHC staining to support biological interpretation.

Does spatial drug distribution reflect drug efficacy?

Spatial distribution reflects local drug exposure, not direct biological activity. Data interpretation is most powerful when combined with histology, pathology, or functional readouts.

Learn about other Q&A.

Sample Submission Guidelines

To ensure reliable spatial drug distribution results, please follow the general guidelines below. Project-specific requirements will be confirmed during pre-study consultation.

Accepted Sample Types

Fresh-frozen tissue or sections (preferred)
Cell pellets or 3D culture models

FFPE samples may be accepted in limited cases; please consult us in advance.

Dosing & Tmax

For optimal results, harvest tissue at the known T_max of the drug to ensure sufficient signal is present for imaging.

Sample Handling & Storage

Snap-freeze samples immediately after collection
Store and ship at –80°C
Avoid repeated freeze–thaw cycles

Quantity Recommendation

Sufficient tissue to obtain multiple sections per sample is recommended for optimal analysis

Spatial Drug Distribution Analysis

Title: Elucidating Gender-Specific Distribution of Imipramine, Chloroquine, and Their Metabolites in Mice Kidney Tissues through AP-MALDI-MSI

Journal: International Journal of Molecular Sciences

Published: 2024

The study emerges from growing recognition that pharmaceutical responses differ significantly between biological sexes, with women experiencing adverse drug reactions at nearly twice the rate of men. While such disparities are increasingly documented in clinical settings, the underlying mechanisms of sex-specific drug distribution at the organ and tissue level remain poorly understood. Conventional analytical approaches like quantitative whole-body autoradiography and liquid chromatography-tandem mass spectrometry have proven limited in capturing spatial distribution patterns of drugs and their metabolites within specific tissue compartments. This knowledge gap is particularly relevant for medications like imipramine and chloroquine, which demonstrate clinically significant sex-based differences in pharmacokinetics but lack detailed tissue-level distribution data that could explain their differential effects and toxicity profiles between males and females.

Spatial distribution of imipramine, chloroquine, and their metabolites was mapped in murine kidney tissues using atmospheric pressure MALDI imaging mass spectrometry (AP-MALDI-MSI). Standardized cryosectioning and matrix application enabled clear visualization of drug localization patterns across control and treated samples.

Spatial mapping revealed distinct sexual dimorphism in the renal localization patterns of imipramine and its metabolic derivatives between male and female murine kidneys (Figure 4A,C). Control kidney tissues from both sexes exhibited no detectable signals for the parent compound or its metabolites, confirming the specificity of the observed drug distributions (Figure 4B,D).

imipramine distribution Figure 4. Localization of imipramine, desipramine, and 2-hydroxy imipramine in male and female mice kidneys.

Spatial mapping revealed sexually dimorphic distribution profiles of chloroquine and its metabolites within murine renal architecture. While both sexes exhibited accumulation in the renal pelvis, striking compartment-specific differences emerged in the medulla: female kidneys demonstrated substantial medullary localization of both parent compound and metabolites, whereas male kidneys displayed negligible medullary signals (Figure 6A,C). The absence of detectable signals in control tissues from both sexes confirmed the specificity of these distribution patterns (Figure 6B,D).

chloroquine distribution Figure 6. Localization ion images of chloroquine, desethylchloroquine, and chloroquine M(-N(C2H5)2) in male and female mice kidneys.

The study establishes that imipramine and chloroquine, along with their metabolites, exhibit sex-specific spatial distribution patterns within distinct kidney compartments of mice—differing not only in concentration but in anatomical localization between males and females. These tissue-level distribution differences provide a mechanistic basis for clinically observed sex disparities in drug efficacy and renal toxicity, underscoring the necessity for sex-tailored dosing strategies.

Reference

Islam, Md Monirul et al. "Elucidating Gender-Specific Distribution of Imipramine, Chloroquine, and Their Metabolites in Mice Kidney Tissues through AP-MALDI-MSI." International journal of molecular sciences vol. 25,9 4840. 29 Apr. 2024, doi:10.3390/ijms25094840

* For Research Use Only. Not for use in diagnostic procedures.

Our customer service representatives are available 24 hours a day, 7 days a week. Inquiry

From Our Clients

"I recently used their proteomics service for a project analyzing protein interactions in yeast models. The team was very responsive and helped clarify the methodology they employed, which made me feel confident in the results. The data quality was solid, with clear identification of several key proteins involved in our study. Their thorough analysis enabled me to pinpoint specific interactions that I hadn't considered before, which significantly improved the direction of my research. I appreciate their professionalism and support throughout the process."

Sarah Thompson, University of California, Berkeley

"Our lab collaborated with them on a project studying cancer biomarkers. The proteomics analysis provided was detailed and focused, specifically highlighting the differential expression of proteins between healthy and tumor samples. Their clear explanations of the data helped my team understand the biological implications. I also appreciated their willingness to revise the reports based on our feedback, ensuring that we had everything we needed for our publication. This collaborative spirit was invaluable."

Emily Rodriguez, Stanford University

"Our lab worked with them on a project studying the effects of diet on gut microbiota using proteomics. They used a label-free quantification method to analyze proteins in fecal samples before and after dietary intervention. The results showed significant changes in protein expression linked to microbial activity. This was pivotal for our hypothesis about diet-microbiota interactions. The clarity of their data presentation made it easy for our team to integrate these findings into our ongoing research."

Dr. Lisa Wong, University of Toronto

"My experience with Creative Proteomics during the mass spectrometry analysis was excellent. We sent in human saliva and mouse brain tissue samples, which they expertly analyzed using both LC-MS and GC-MS techniques. The results were invaluable, revealing key metabolites in the saliva and identifying biomarkers linked to brain function in the brain tissue."

Dr. Emily Carter, Senior Research Scientist

"The overall service from Creative Proteomics was outstanding. They made the entire process seamless and efficient, allowing us to focus on our research. We worked with leaf and root samples from various Arabidopsis genotypes for targeted metabolomics analysis. Their thorough profiling of primary and secondary metabolites gave us important insights into how the plants respond metabolically to environmental stress."

Dr. Laura Henderson, Plant Physiologist

"We had a pleasant collaboration with Creative Proteomics on mass spectrometry analysis of lipids. They conducted a detailed analysis of lipid species, providing us with important insights into lipid metabolism and its relationship with metabolic syndrome disease states."

Dr. Sarah Mitchell, Research Scientist

Online Inquiry

Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to for inquiries.

Great Minds Choose Creative Proteomics